SCHEMBL4726921

SCHEMBL4726921

CCOC(=O)c1ccc2c(c1)c1c(n2CCCOc2ccccc2)CCC(C(=O)OCC)C1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SCARB1 Q8WTV0 2/20 0.46
▸ NPC1 O15118 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ EGFR P00533 2/20 0.44
▸ IGF1R P08069 2/20 0.44
▸ FLT4 P35916 2/20 0.44
▸ KDR P35968 2/20 0.44
▸ HTR5A P47898 1/20 0.41
▸ HRH3 Q9Y5N1 2/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ LTA4H P09960 1/20 0.41
▸ PTGER4 P35408 1/20 0.40
▸ AKR1C4 P17516 1/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ AKR1C3 P42330 1/20 0.39
▸ AKR1C2 P52895 1/20 0.39
▸ AKR1C1 Q04828 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5810777 0.77 PTGDR2 (0.48) NPC1ALDH1A1RAB9A
SCHEMBL5811928 0.72 ALDH1A1 (0.47) ALDH1A1TSHRAKR1C4PTGS1AKR1C3
SCHEMBL4780961 0.72 SCARB1 (0.61) SCARB1NPC1ALDH1A1RAB9A
SCHEMBL8388005 0.72 PTGDR2 (0.51) ALDH1A1TSHRKCNH2
SCHEMBL2020046 0.71 CNR1 (0.55) —
SCHEMBL4727932 0.70 SCARB1 (0.54) SCARB1NPC1RAB9AHTR5A
SCHEMBL22134575 0.69 AKR1C4 (0.39) NPC1ALDH1A1RAB9AAKR1C4PTGS1
SCHEMBL11836306 0.68 AKR1C3 (0.48) ALDH1A1TSHRAKR1C4PTGS1AKR1C3
SCHEMBL10460820 0.68 LTA4H (0.73) NPC1ALDH1A1TSHRRAB9AEGFR
SCHEMBL13011086 0.68 PTGDR2 (0.45) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008021745-A2 HEPATITIS C VIRUS ENTRY INHIBITORS ITHERX PHARMACEUTICALS, INC. (US) 2008-02-21 — — WO disclosed
Send feedback